JW Pharmaceutical Corporation (KRX:001060)
South Korea
· Delayed Price · Currency is KRW 30,700
-1,600 (-4.95%)
At close: Mar 9, 2026
JW Pharmaceutical Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 701,296 | 561,695 | 828,523 | 419,688 | 505,678 | 753,056 | Upgrade
|
| Market Cap Growth | 24.83% | -32.20% | 97.41% | -17.00% | -32.85% | 22.16% | Upgrade
|
| Enterprise Value | 687,448 | 600,784 | 959,912 | 491,395 | 649,827 | 873,041 | Upgrade
|
| Last Close Price | 30700.00 | 24000.00 | 34877.84 | 17456.16 | 20654.29 | 30394.81 | Upgrade
|
| PE Ratio | 12.24 | 9.24 | 22.39 | 13.16 | - | - | Upgrade
|
| PS Ratio | 0.92 | 0.78 | 1.11 | 0.61 | 0.83 | 1.38 | Upgrade
|
| PB Ratio | 1.98 | 1.71 | 3.12 | 1.86 | 2.68 | 3.63 | Upgrade
|
| P/TBV Ratio | 2.04 | 1.76 | 3.29 | 1.84 | 2.68 | 3.86 | Upgrade
|
| P/FCF Ratio | 8.99 | 7.90 | 13.84 | 8.96 | 47.45 | 14.86 | Upgrade
|
| P/OCF Ratio | 7.99 | 7.08 | 9.51 | 7.39 | 27.90 | 11.94 | Upgrade
|
| EV/Sales Ratio | 0.90 | 0.84 | 1.28 | 0.72 | 1.07 | 1.60 | Upgrade
|
| EV/EBITDA Ratio | 5.84 | 5.90 | 8.05 | 6.36 | 13.84 | 45.08 | Upgrade
|
| EV/EBIT Ratio | 6.94 | 7.26 | 9.93 | 8.12 | 21.07 | - | Upgrade
|
| EV/FCF Ratio | 8.81 | 8.45 | 16.03 | 10.49 | 60.98 | 17.23 | Upgrade
|
| Debt / Equity Ratio | 0.19 | 0.28 | 0.64 | 0.93 | 1.30 | 0.88 | Upgrade
|
| Debt / EBITDA Ratio | 0.59 | 0.90 | 1.43 | 2.71 | 5.22 | 9.41 | Upgrade
|
| Debt / FCF Ratio | 0.88 | 1.29 | 2.84 | 4.47 | 23.00 | 3.60 | Upgrade
|
| Net Debt / Equity Ratio | -0.04 | 0.18 | 0.29 | 0.27 | 0.95 | 0.61 | Upgrade
|
| Net Debt / EBITDA Ratio | -0.12 | 0.58 | 0.64 | 0.77 | 3.82 | 6.55 | Upgrade
|
| Net Debt / FCF Ratio | -0.18 | 0.83 | 1.27 | 1.28 | 16.84 | 2.51 | Upgrade
|
| Asset Turnover | 1.22 | 1.15 | 1.18 | 1.09 | 1.03 | 0.98 | Upgrade
|
| Inventory Turnover | 3.54 | 3.64 | 3.79 | 3.70 | 3.65 | 3.86 | Upgrade
|
| Quick Ratio | 0.94 | 0.82 | 0.90 | 0.80 | 0.79 | 0.78 | Upgrade
|
| Current Ratio | 1.51 | 1.47 | 1.32 | 1.12 | 1.30 | 1.27 | Upgrade
|
| Return on Equity (ROE) | 19.09% | 21.87% | 15.65% | 14.41% | -0.73% | -6.98% | Upgrade
|
| Return on Assets (ROA) | 9.74% | 8.28% | 9.49% | 6.00% | 3.26% | -0.15% | Upgrade
|
| Return on Invested Capital (ROIC) | 19.92% | 17.88% | 21.60% | 12.18% | -0.62% | -0.37% | Upgrade
|
| Return on Capital Employed (ROCE) | 24.90% | 20.90% | 27.00% | 24.40% | 8.80% | -0.40% | Upgrade
|
| Earnings Yield | 8.27% | 11.58% | 4.47% | 7.60% | -0.19% | -2.02% | Upgrade
|
| FCF Yield | 11.13% | 12.65% | 7.23% | 11.16% | 2.11% | 6.73% | Upgrade
|
| Dividend Yield | 1.39% | 1.88% | - | - | - | - | Upgrade
|
| Payout Ratio | 17.63% | 14.86% | 23.82% | 23.05% | - | - | Upgrade
|
| Buyback Yield / Dilution | 2.90% | 2.01% | -2.49% | -0.07% | 0.05% | -0.04% | Upgrade
|
| Total Shareholder Return | 4.30% | 3.89% | -2.49% | -0.07% | 0.05% | -0.04% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.